Pfizer To Issue Trovan I.V. "Dear Doctor" Letter With Labeling Changes
Executive Summary
Pfizer will notify health care professionals of Trovan I.V. labeling changes due to incompatibility with .9% sodium chloride injection via a "Dear Doctor" letter after receiving a warning letter from FDA.